A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Clinical trial NCT06325657 · COMPLETED

Trial details

NCT number: NCT06325657
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2024-03-12
Primary completion: 2025-06-11
Enrollment: 681

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.